Emily – Cohort studies
Emily is part of two cohort studies (kidneys and biobanking). She has also taken part in many other types of medical research. Her participation has involved blood tests, urine tests, and having her blood pressure monitored.
Emily is part of a kidney health cohort study. Her memory of how she found the study is hazy, but she believes she may have joined through Facebook as she often joins other medical research studies this way. However, it may have also been through her GP who wrote a letter to invite her to the study. Emily has previously allowed researchers to share her contact details. She believes this may also be why she has been recruited to the kidney cohort study. Another study Emily was a part of, on Alzheimer’s, was a result of Facebook advertisements. Sometimes, Emily has joined medical research studies because of written letters or poster advertisements on notice boards.
The kidney cohort study that Emily is a part of has lasted for many years. In this study, she has routine blood tests, urine tests, and blood pressure monitored. At first, this was every 6 months and then every year. She has also been given a blood pressure monitor to use twice a day at home where she writes down the recordings. She cannot remember how long she had to test her blood pressure for. Emily has found this study interesting and, apart from the blood test, non-invasive and “very easy to do”. Her participation now involves seeing her nurse once a year, which Emily describes as convenient as she does not have to travel far. In these appointments, she has her height and weight checked and she is asked questions about how she is feeling.
Emily is also a part of a biobanking cohort study. When she joined about four or five years ago, she had her blood tested, urine tested and her height and weight measured. She joined this cohort study in particular because it “seemed like a good idea” and to contribute to medical knowledge.
Emily is motivated to take part in medical research as she believes it benefits society. The research she has taken part in has been about collecting information rather than Emily having to take or undergo any interventions, apart from the Alzheimer’s study which involved taking medication. However, this study was cancelled because of concerns over the side-effects of the drug. Emily is also motivated to take part in medical research because she can learn about her own health. In the kidney cohort study she is a part of, for example, she has received feedback about her slow kidney. She believes she would not have found this information out if it was not for her involvement in the cohort study. She is happy with this level of feedback and believes that if there was anything seriously wrong with her then the researchers would tell her.
Emily believes medical research that involves taking a trial drug can be risky. However, she described the researchers she’s met as being “very thorough about telling you about the risk” of taking part. She also believes that taking part in medical research may involve finding out information about your body that you do not want to know about and it may be a burden if you have to travel far away from your home. This is why she tries to take part in studies that are close to where she lives. She will only go to studies outside of her area if they really interest her. The message that Emily has for people who are invited to take part in cohort studies is that “if you’ve got the time to do it, it can be extremely interesting and very rewarding”.
Interview conducted in 2019.